Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
- PMID: 16946302
- PMCID: PMC1895450
- DOI: 10.1182/blood-2006-05-024042
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
Abstract
We previously compared outcomes after allogeneic peripheral-blood stem cell (PBSC) and bone marrow (BM) transplantation in 706 patients with leukemia. We obtained long-term follow up on 413 of 491 patients who were alive at the time of the initial report: 141 PBSC and 272 BM recipients. Chronic graft-versus-host disease (GVHD) was more frequent after PBSC compared to BM transplantation (RR 1.65, P < .001) yet relapse rates were similar in both groups. Leukemia-free survival rates were higher after PBSC than BM transplantation for patients with advanced chronic myeloid leukemia (33% versus 25%) but lower for those in first chronic phase (41% versus 61%) due to higher rates of late transplant-related mortality. Leukemia-free survival was similar after PBSC and BM transplantation for acute leukemia. These data represent the early experience with PBSC grafts. Long-term outcomes in recipients of more recent transplants are required to better evaluate the role of PBSC grafts relative to BM transplantation.
Figures
![Figure 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc63/1895450/f8a1c3ec08f9/zh80240605160001.gif)
Similar articles
-
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.J Hematol Oncol. 2017 Jul 4;10(1):135. doi: 10.1186/s13045-017-0503-2. J Hematol Oncol. 2017. PMID: 28676100 Free PMC article. Clinical Trial.
-
Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.J Clin Oncol. 2004 Dec 15;22(24):4872-80. doi: 10.1200/JCO.2004.02.189. Epub 2004 Nov 1. J Clin Oncol. 2004. PMID: 15520055
-
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.Biol Blood Marrow Transplant. 2012 Sep;18(9):1422-9. doi: 10.1016/j.bbmt.2012.02.013. Epub 2012 Mar 20. Biol Blood Marrow Transplant. 2012. PMID: 22446014
-
Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Exp Hematol. 2016 Jul;44(7):567-73. doi: 10.1016/j.exphem.2016.04.005. Epub 2016 Apr 19. Exp Hematol. 2016. PMID: 27106798 Review.
-
Peripheral Blood or Bone Marrow Stem Cells? Practical Considerations in Hematopoietic Stem Cell Transplantation.Transfus Med Rev. 2019 Jan;33(1):43-50. doi: 10.1016/j.tmrv.2018.11.003. Epub 2018 Nov 12. Transfus Med Rev. 2019. PMID: 30528986 Review.
Cited by
-
Efficacy of pretreatment of allografts with methoxypolyethylene glycol-succinimidyl-propionic acid ester in combination with an anti-OX40L monoclonal antibody in relieving graft-versus-host disease in mice.Int J Hematol. 2010 Nov;92(4):609-16. doi: 10.1007/s12185-010-0701-y. Epub 2010 Oct 17. Int J Hematol. 2010. PMID: 20953915
-
Animal Models for Preclinical Development of Allogeneic Hematopoietic Cell Transplantation.ILAR J. 2018 Dec 31;59(3):263-275. doi: 10.1093/ilar/ily006. ILAR J. 2018. PMID: 30010833 Free PMC article.
-
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.Biol Blood Marrow Transplant. 2011 Jul;17(7):1018-24. doi: 10.1016/j.bbmt.2010.10.029. Epub 2010 Oct 27. Biol Blood Marrow Transplant. 2011. PMID: 21034842 Free PMC article.
-
Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?Cytotherapy. 2009;11(4):464-71. doi: 10.1080/14653240902849788. Cytotherapy. 2009. PMID: 19513902 Free PMC article.
-
Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician's perspective.Lifetime Data Anal. 2008 Dec;14(4):379-88. doi: 10.1007/s10985-008-9090-4. Epub 2008 Jul 8. Lifetime Data Anal. 2008. PMID: 18607725 Review.
References
-
- Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood. 2000;95: 3702-3709. - PubMed
-
- Powles R, Metha J, Kulkarni S, et al. Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: a randomized trial. Lancet. 2000;355: 1231-1237. - PubMed
-
- Blaise D, Kuentz M, Fortainer C, et al. Randomized trial of bone marrow versus lenograstimprimed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Franciase de Greffe de Molle. J Clin Oncol. 2000;18: 537-546. - PubMed
-
- Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344: 175-181. - PubMed
-
- Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral blood stem cell and bone marrow transplantation. J Clin Oncol. 2001;19: 3685-3691. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical